REFERENCES
- Teele DW, Klein JO, Rosner B, the Greater Boston Otitis Media Study Group. Epidemiology of otitis media during the first seven years of life in children in Greater Boston: a prospective cohort study. J Infect Dis 1989; 160: 83–94.
- Bluestone CD. Current therapy for otitis media and criteria for evaluation of new antimicrobial agents. Clin Infect Dis 1992; 14 (suppl 2): S197-203.
- Aronovitz G. A multicentre, open label trial of azithromycin vs. amoxicillin/clavulanate for the management of acute otitis media in children. Pediatr Infect Dis J 1996; 15: S15–9.
- Behre U, Burow H-M, Quinn P, Cree F, Harrison HE. Efficacy of twice daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection 1997; 25: 163–6.
- Hoberman A, Paradise JL, Burch DJ, et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatr Infect Dis J 1997; 16: 463–70.
- McLinn S. A multicentre, double-blind comparison of azithromycin and amoxicillin/clavulanate for the treatment of acute otitis media in children. Pediatr Infect Dis J 1996; 15: S20–3.
- Kaleida PH, Bluestone CD, Rockette HE, et al. Amoxycillin-clavulanate potassium compared with cefaclor for acute otitis media in infants and children. Pediatr Infect Dis J 1987; 6: 265–71.
- Jacobsson S, Rigner P, von Sydow C, Bondesson G. Recurrent and penicillin V-resistant otitis media: a treatment study with amoxycillin-clavulanate and cefaclor. Acta Otolaryngol 1988; 106: 171–7.
- Marchant CD, Shurin PA, Johnson CE, et al. A randomized controlled trial of amoxycillin plus clavulanate compared with cefaclor for the treatment of acute otitis media. J Pediatr 1986; 109: 891–6.
- Odio CM, Kusmiesz H, Shelton S, Nelson JD. Comparative treatment trial of Augmentin versus cefaclor for acute otitis media with effusion. Pediatrics 1985; 75: 819–26.
- Dagan R, Piglansky L, Yagupsy P, Fliss DM, Leiberman A, Leibovitz E. Bacteriologic response in acute otitis media (AOM): comparison between azithromycin (AZ), cefaclor (CEC) and amoxicillin (AMOX). Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto 1997. American Society for Microbiology. Abstract no K-103, page 346.
- Craig WA. Antimicrobial resistance issues of the future. Diagn Microbiol Infect Dis 1996; 25: 213–7.
- Craig WA, Andes D. Pharmacokinetics and pharmaco-dynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996; 15: 255–9.
- Craig WA. The future - can we learn from the past? Diagn Microbiol Infect Dis 1997; 27: 49–53.
- Dagan R, Abramson O, Leibovitz E, et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media (AOM) caused by intermediately penicillin-resistant pneumococci (I-PRP). Proceedings of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington 1995; abstr LB-25. American Society for Microbiology.
- Calver AD, Walsh NS, Quinn PF, et al. Dosing of amoxicillin/clavulanate given every 12 hours is as effective as dosing every 8 hours for treatment of lower respiratory tract infection. Clin Infect Dis 1997; 24: 570–4.
- Cook RC, Zachariah J, Cree F, Harrison HE. Efficacy of twice-daily amoxycillin/clavulanate (`Augmentin-duo' 400/57) in mild to moderate lower respiratory tract infection in children. Br J Clin Pract 1996; 50: 125–8.
- Gooch III WM, Philips A, Rhoades R, Rosenberg R, Schaten R, Starobin S. Comparison of the efficacy, safety and acceptability of cefixime and amoxycillin/clavulanate in acute otitis media. Pediatr Infect Dis J 1997; 16: S21–4.